glyburide has been researched along with dobutamine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Pfeifer, MA; Rothschild, AH; Rothschild, MA | 1 |
| McCulloch, AI; Randall, MD | 1 |
| Kübler, W; Niroomand, F; Tiefenbacher, CP; Tillmanns, H; Zimmermann, R | 1 |
| Brooks, LA; Dellsperger, KC; Embrey, RP | 1 |
| Du Toit, EF; McCarthy, J; Muller, CA; Opie, LH | 1 |
| Criniti, A; del Monte, F; Ducouret, P; Iwashiro, K; Monti, F; Papalia, U; Picard, S; Puddu, PE; Rouet, R; Ruvolo, G; Tonelli, E | 1 |
| Campa, PP; Criniti, A; Iwashiro, K; La Francesca, S; Marino, B; Monti, F; Papalia, U; Picard, S; Puddu, PE; Ruvolo, G | 1 |
| Hu, Q; Kelly, RF; Kuskowski, M; Lee, J; Mansoor, A; McFalls, EO; Sikora, J; Ward, HB; Zhang, J | 1 |
1 review(s) available for glyburide and dobutamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for glyburide and dobutamine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
The inotropic action of tolbutamide and glyburide.
Topics: Administration, Oral; Adult; Blood Glucose; Blood Pressure; Dobutamine; Epinephrine; Glyburide; Humans; Male; Myocardial Contraction; Norepinephrine; Propranolol; Stroke Volume; Tolbutamide | 1989 |
The involvement of ATP-sensitive potassium channels in beta-adrenoceptor-mediated vasorelaxation in the rat isolated mesenteric arterial bed.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Binding, Competitive; Bucladesine; Dihydroalprenolol; Dobutamine; Glyburide; In Vitro Techniques; Isoproterenol; Male; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium Channel Blockers; Potassium Channels; Radioligand Assay; Rats; Rats, Wistar; Terbutaline; Vasodilation; Vasodilator Agents; Verapamil | 1995 |
Adaptation of myocardial blood flow to increased metabolic demand is not dependent on endothelial vasodilators in the rat heart.
Topics: Acetylcholine; Adaptation, Physiological; Adrenergic beta-1 Receptor Agonists; Animals; Coronary Circulation; Cyclooxygenase Inhibitors; Dobutamine; Female; Glyburide; Indomethacin; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Perfusion; Potassium Channels; Rats; Rats, Wistar; Regional Blood Flow; Vasodilator Agents | 1997 |
Mechanism of coronary microvascular responses to metabolic stimulation.
Topics: Adrenergic beta-Agonists; Animals; Cardiac Pacing, Artificial; Coronary Vessels; Dobutamine; Dogs; Female; Glyburide; Hypoglycemic Agents; Male; Microcirculation; Nitric Oxide Synthase; Nitroarginine; Oxygen Consumption; Potassium Channel Blockers; Stimulation, Chemical; Vasodilation | 1997 |
Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Agonists; Calcium Channel Blockers; Cyclic AMP; Cyclic GMP; Dobutamine; Glyburide; Guinea Pigs; Heart; Hydrazones; In Vitro Techniques; L-Lactate Dehydrogenase; Lactic Acid; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nucleotides, Cyclic; Phosphocreatine; Pyridazines; Simendan; Stereoisomerism | 1999 |
Protection of human myocardium in vitro by K(ATP) activation with low concentrations of bimakalim.
Topics: Adenosine Triphosphate; Adult; Benzopyrans; Dihydropyridines; Dobutamine; Dose-Response Relationship, Drug; Drug Interactions; Glyburide; Heart Atria; Humans; Hypoxia; In Vitro Techniques; Isometric Contraction; Muscle Contraction; Myocardial Contraction; Myocardium; Oxygen; Potassium Channels; Time Factors | 1999 |
Adenosine triphosphate-dependent potassium channel modulation and cardioplegia-induced protection of human atrial muscle in an in vitro model of myocardial stunning.
Topics: Adenosine Triphosphate; Adult; Aged; Atrial Function, Right; Benzopyrans; Bicarbonates; Calcium Chloride; Cardioplegic Solutions; Cardiotonic Agents; Cell Hypoxia; Dihydropyridines; Dobutamine; Female; Glyburide; Heart Arrest, Induced; Humans; In Vitro Techniques; Magnesium; Male; Middle Aged; Myocardial Contraction; Myocardial Stunning; Potassium Channel Blockers; Potassium Channels; Potassium Chloride; Sodium Chloride | 2000 |
The energetic state within hibernating myocardium is normal during dobutamine despite inhibition of ATP-dependent potassium channel opening with glibenclamide.
Topics: Adenosine Triphosphate; Animals; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Drug Interactions; Energy Metabolism; Glyburide; Hypoglycemic Agents; Ion Channel Gating; Myocardial Stunning; Potassium Channels; Swine | 2007 |